Creating stem cell specimen bank

2015061000113_sinya

Stem cells specialist Professor in Japan, Yamanaka Shinya made a speech about stem cell future on World Conference of Science Jounalists 2015.

By creating stem cell specimen bank, which enables affordable benefits, but we will have to wait 10 years utilizing

Next year, the treatment of Parkinson’s disease clinical trials using pluripotent stem cells (iPS) induced in Japan begins. This is a new challenge, we hope hopeful results. But stem cell therapy is not a panacea that can be used immediately obvious. We have the patience to wait 10 years. The true objective of the science is to develop a technology that can be used for everyone than to obtain a particular good results.
Professor Shinya Yamanaka said at the opening ceremony in World Conference of Science Jounalists 2015,"
We always strive to not give too much fantasy to instill incurable patients and their families."
In 2007, Professor Yamanaka developed the technique to revert to embryonic stem cells (in raw cells in the embryo, and can grow in the body of all cells) by putting the growth control genes in the adult skin cells to mature adult.
The cells thus created are called iPS.




The iPS cells can also be skin, heart cells can also be.

These cells are no rejection of transplant because the patient’s own cells and no ethical issues unlike embryonic stem cells.
Last year, Japanese researchers transplanted iPS cells into the eyes of age-related macular degeneration (AMD : gradual loss of the eye disease) patients, seven months after the results, that prevented eyesight to deteriorate.
Recently, using the iPS cell made of blood.
If we can produce the blood cells by iPS, there is no need to worry about the lack of blood donor in aging society. And immune cell production researches by iPS are attainable for the increasing immunity of the elderly.

He is trying to make iPS cells bank recently.

For no rejection, patients basically use their own cells. However, creating one of the iPS need at least cost more than $ 1 million is to use cultivation after.
Professor Yamanaka said, “In studies of hundreds of people, creating about 140 pieces of the iPS, 90% more than people can use without rejection.
"This 140 iPS cells made in consultation with universities, hospitals, and government who need to take advantage of all archived after handing over the country." he explained.
When he was a resident, His father suddenly died from diabetes and hepatitis, which changed his life. He said, "I realized then that the disease did not heal this world too much. People are dying like his father decided he would not make the world, and changed the course based medicine."
Although doctors as dunce in the past, he is the world top scholar. "The secret is the effort to learn from wrong." he said. If science often come out unintended results, then it is crucial that the right opportunity to discover new things.

Edited by AllStemCells.com


Shinya Yamanaka : Professor of Kyoto University

Director of Center for iPS Cell (induced Pluripotent Stem Cell) Research and Application
– School of Medicine, Kobe University
– Postdoctoral Fellowship, Gladstone Institute, University of California in San Francisco
– Professor of Genetic Education Research Center, Nara Institute of Science and Technology (2003)
– Professor of Regenerative Medicine Institute, Kyoto University (2004~2007)
– Senior Researcher, Gladstone Institute (2007~ )
– Professor of Integrated Cell-Material Sciences, Kyoto University (2007~2010)
– The first successful implementation of iPS using rat skin cells in 2006
– Winner of 2009 Albert Lasker Basic Medical Research Award and 2012
– Nobel Prize in Physiology or Medicine for iPS implementation Merit(2012)

Photo Source : https://www.wcsj2015.or.kr






Tagged with:

Related Articles